Key trends and projections shaping the year ahead.

Overview of emerging and established innovation centers.

Global progress in CGT development and approvals.

Current landscape and competitive analysis in oncology.

R&D focus and progress in rare and orphan conditions.

Recent deals, valuations, and acquisition patterns.